Cargando…
Treatment of Melanoma Metastasis: Surgical, Chemotherapy, and Innovation
Melanoma is a form of skin cancer with an increased ability to metastasis to organs such as the brain and other visceral organs, contributing to its aggressiveness and seriousness. Melanoma’s prevalence around the globe rapidly continues to rise. Melanoma development is a complex process often depic...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208434/ https://www.ncbi.nlm.nih.gov/pubmed/37228900 |
_version_ | 1785046666197336064 |
---|---|
author | Rosen, Chelsea Mayes, Taeya Overholt, Claire Lucke-Wold, Brandon |
author_facet | Rosen, Chelsea Mayes, Taeya Overholt, Claire Lucke-Wold, Brandon |
author_sort | Rosen, Chelsea |
collection | PubMed |
description | Melanoma is a form of skin cancer with an increased ability to metastasis to organs such as the brain and other visceral organs, contributing to its aggressiveness and seriousness. Melanoma’s prevalence around the globe rapidly continues to rise. Melanoma development is a complex process often depicted as a step-wise process with the potential to end in metastatic disease. Recent studies suggest that the process could be non-linear. Melanoma has many risk factors including genetics, UV exposure, or exposure to carcinogens. Current treatments for metastatic melanoma include surgery, chemotherapy, and immune checkpoint inhibitors (ICIs); however, each of these treatments comes with limitations, toxicities, and relatively poor outcomes. There are various guidelines set by the American Joint Committee on Cancer guiding surgical treatment options based on the site of metastasis. Surgical treatments cannot fully treat widespread metastatic melanoma but can contribute to better patient outcomes overall. Many chemotherapy options are ineffective against melanoma or come with extreme toxicities; however, alkylating agents, platinum analogs, and microtubular toxins have shown some effectiveness against metastatic melanoma. ICIs are a relatively new treatment option and offer a promising option for patients; however, ICIs are subject to tumor resistance mechanisms and are not effective for every metastatic melanoma patient. Due to the limitations of conventional treatments, there is a need for newer and more effective treatment options for metastatic melanoma. This review aims to highlight the current surgical, chemotherapy, and ICI treatments for metastatic melanoma, as well as current clinical and preclinical investigations to discover revolutionary options for patients. |
format | Online Article Text |
id | pubmed-10208434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
record_format | MEDLINE/PubMed |
spelling | pubmed-102084342023-05-24 Treatment of Melanoma Metastasis: Surgical, Chemotherapy, and Innovation Rosen, Chelsea Mayes, Taeya Overholt, Claire Lucke-Wold, Brandon Med Discov Article Melanoma is a form of skin cancer with an increased ability to metastasis to organs such as the brain and other visceral organs, contributing to its aggressiveness and seriousness. Melanoma’s prevalence around the globe rapidly continues to rise. Melanoma development is a complex process often depicted as a step-wise process with the potential to end in metastatic disease. Recent studies suggest that the process could be non-linear. Melanoma has many risk factors including genetics, UV exposure, or exposure to carcinogens. Current treatments for metastatic melanoma include surgery, chemotherapy, and immune checkpoint inhibitors (ICIs); however, each of these treatments comes with limitations, toxicities, and relatively poor outcomes. There are various guidelines set by the American Joint Committee on Cancer guiding surgical treatment options based on the site of metastasis. Surgical treatments cannot fully treat widespread metastatic melanoma but can contribute to better patient outcomes overall. Many chemotherapy options are ineffective against melanoma or come with extreme toxicities; however, alkylating agents, platinum analogs, and microtubular toxins have shown some effectiveness against metastatic melanoma. ICIs are a relatively new treatment option and offer a promising option for patients; however, ICIs are subject to tumor resistance mechanisms and are not effective for every metastatic melanoma patient. Due to the limitations of conventional treatments, there is a need for newer and more effective treatment options for metastatic melanoma. This review aims to highlight the current surgical, chemotherapy, and ICI treatments for metastatic melanoma, as well as current clinical and preclinical investigations to discover revolutionary options for patients. 2023 2023-04-14 /pmc/articles/PMC10208434/ /pubmed/37228900 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Rosen, Chelsea Mayes, Taeya Overholt, Claire Lucke-Wold, Brandon Treatment of Melanoma Metastasis: Surgical, Chemotherapy, and Innovation |
title | Treatment of Melanoma Metastasis: Surgical, Chemotherapy, and Innovation |
title_full | Treatment of Melanoma Metastasis: Surgical, Chemotherapy, and Innovation |
title_fullStr | Treatment of Melanoma Metastasis: Surgical, Chemotherapy, and Innovation |
title_full_unstemmed | Treatment of Melanoma Metastasis: Surgical, Chemotherapy, and Innovation |
title_short | Treatment of Melanoma Metastasis: Surgical, Chemotherapy, and Innovation |
title_sort | treatment of melanoma metastasis: surgical, chemotherapy, and innovation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208434/ https://www.ncbi.nlm.nih.gov/pubmed/37228900 |
work_keys_str_mv | AT rosenchelsea treatmentofmelanomametastasissurgicalchemotherapyandinnovation AT mayestaeya treatmentofmelanomametastasissurgicalchemotherapyandinnovation AT overholtclaire treatmentofmelanomametastasissurgicalchemotherapyandinnovation AT luckewoldbrandon treatmentofmelanomametastasissurgicalchemotherapyandinnovation |